BORTOLUZZI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 9.849
AS - Asia 6.907
EU - Europa 2.904
SA - Sud America 1.191
AF - Africa 455
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 21.394
Nazione #
US - Stati Uniti d'America 9.495
SG - Singapore 2.449
CN - Cina 1.330
BR - Brasile 814
IT - Italia 708
VN - Vietnam 661
HK - Hong Kong 604
DE - Germania 425
GB - Regno Unito 372
ID - Indonesia 321
FR - Francia 287
JP - Giappone 251
IN - India 250
EG - Egitto 230
TR - Turchia 224
FI - Finlandia 218
UA - Ucraina 175
RU - Federazione Russa 167
IQ - Iraq 160
MX - Messico 160
CA - Canada 142
AR - Argentina 101
EC - Ecuador 93
SE - Svezia 87
PH - Filippine 81
PL - Polonia 81
BD - Bangladesh 80
NL - Olanda 78
ZA - Sudafrica 73
AU - Australia 72
PK - Pakistan 70
ES - Italia 59
SA - Arabia Saudita 57
IR - Iran 56
TW - Taiwan 51
CO - Colombia 49
MY - Malesia 48
AT - Austria 38
VE - Venezuela 35
PE - Perù 34
IE - Irlanda 33
KE - Kenya 33
CL - Cile 31
KR - Corea 31
BE - Belgio 29
UZ - Uzbekistan 26
DZ - Algeria 24
NG - Nigeria 20
TH - Thailandia 20
HU - Ungheria 19
MA - Marocco 19
JO - Giordania 18
BO - Bolivia 17
RO - Romania 17
CZ - Repubblica Ceca 16
IL - Israele 15
LT - Lituania 15
NZ - Nuova Zelanda 13
AE - Emirati Arabi Uniti 12
GR - Grecia 12
PT - Portogallo 12
TN - Tunisia 12
KZ - Kazakistan 11
LB - Libano 10
CH - Svizzera 9
DK - Danimarca 9
PS - Palestinian Territory 9
KW - Kuwait 8
NO - Norvegia 8
NP - Nepal 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
CR - Costa Rica 7
HN - Honduras 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
OM - Oman 6
AL - Albania 5
LK - Sri Lanka 5
LY - Libia 5
MM - Myanmar 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
ET - Etiopia 4
KH - Cambogia 4
NI - Nicaragua 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BF - Burkina Faso 3
BH - Bahrain 3
CG - Congo 3
CU - Cuba 3
CY - Cipro 3
KG - Kirghizistan 3
LV - Lettonia 3
MG - Madagascar 3
PA - Panama 3
Totale 21.340
Città #
Singapore 1.430
Ashburn 1.361
Fairfield 893
San Jose 667
Santa Clara 576
Woodbridge 569
Hong Kong 562
Beijing 449
Dallas 372
Houston 367
Seattle 347
Chandler 302
Cambridge 296
Wilmington 285
Ho Chi Minh City 231
Ann Arbor 224
Council Bluffs 213
Los Angeles 205
Tokyo 201
Jakarta 190
Jacksonville 171
Hanoi 161
Lauterbourg 135
Helsinki 131
New York 127
Ferrara 115
Princeton 115
Izmir 109
Munich 104
Nanjing 85
Shanghai 81
Baghdad 80
São Paulo 76
San Diego 71
Warsaw 69
London 67
Cairo 64
Orem 63
Alexandria 59
Mexico City 57
Chicago 55
Frankfurt am Main 49
Montreal 49
Milan 44
Atlanta 40
Boardman 37
Buffalo 36
The Dalles 36
Boston 35
Brooklyn 34
Stockholm 34
Toronto 34
Turku 34
Denver 33
Hefei 33
Bologna 32
Quito 32
Rio de Janeiro 32
Da Nang 30
Dearborn 29
Haiphong 29
Johannesburg 29
Nuremberg 29
Tanta 29
Rome 27
Chennai 26
Falkenstein 26
Lappeenranta 26
Nairobi 26
Poplar 26
Ankara 25
Moscow 25
Sydney 25
Phoenix 24
Redwood City 24
Tianjin 24
Dublin 23
Manchester 23
Shenyang 23
Tashkent 23
Amsterdam 22
Brussels 22
Guayaquil 22
San Francisco 22
Nanchang 21
Riyadh 21
Medan 20
Mumbai 20
Athens 19
Bengaluru 19
Bremen 19
Istanbul 18
Jiaxing 18
New Delhi 18
Taipei 18
Budapest 17
Lahore 17
Mountain View 17
Padova 17
Petaling Jaya 17
Totale 13.314
Nome #
Systemic lupus erythematosus: one year in review 2023 923
One year in review 2022: systemic lupus erythematosus 445
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 336
Novel insights into the management of rheumatoid arthritis: one year in review 2022 285
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 280
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 273
Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors 265
Novel insights into the management of rheumatoid arthritis: one year in review 2023 259
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 239
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 236
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: Analysis of a large monocentric cohort with a long-term follow-up 234
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 230
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 222
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 218
One year in review 2020: systemic lupus erythematosus 211
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 210
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 208
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 207
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 205
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 203
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study 202
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 200
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus 195
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 194
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 192
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 190
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatic 188
One year in review 2021: systemic lupus erythematosus 187
How I treat patients with adult onset Still's disease in clinical practice 186
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET 184
PHARMACOLOGICAL ROLE OF A2A ADENOSINE RECEPTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS, CLINICAL AND LABORATORY CORRELATIONS 184
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 174
Overlap fra neuro-LES e sindromi demielinizzanti 174
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus 174
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 174
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 171
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 170
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 170
Biological and synthetic target DMARDs in psoriatic arthritis 169
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 169
Italian society for Rheumatology recommendations for the management of hand osteoarthritis 168
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 168
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 168
Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides 167
SNP (1513A > C AND 489C > T) OF P2X7 RECEPTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH SEROSITIS 162
Italian Society of Rheumatology recommendations for the management of gout 158
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 157
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 155
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 155
Colour Duplex Ultrasonography in the Diagnosis and Management of Giant Cell Arteritis 154
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 153
Comment on: Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: Time to untie the Gordian knot? 152
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 152
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 151
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 148
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 147
Systemic lupus erythematosus: State of the art on clinical practice guidelines 145
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 144
Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study 144
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 143
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 142
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 142
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 142
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 141
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 141
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 140
Systemic lupus erythematosus: one year in review 2024 139
One year in review 2018: novelties in the treatment of rheumatoid arthritis 139
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 135
Adenosine and adenosine receptors in rheumatoid arthritis 133
Improved pregnancy outcome in patients with Rheumatoid Arthritis who followed an ideal clinical pathway 133
COLOR DOPPLER ULTRASONOGRAPHY IN THE DIAGNOSIS AND MANAGEMENT OF GIANT CELL ARTERITIS. 132
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 132
Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus 131
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 128
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 127
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 127
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 125
The Italian society for rheumatology clinical practice guidelines for rheumatoid arthritis 124
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 122
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 121
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 120
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 120
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 119
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 116
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 114
The Italian society for rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis 114
Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept 113
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus:experience from a tertiary referral centre. 112
The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout 111
Single-photon-emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement. 110
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 110
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment 108
Lupus or not? SLE Risk Probability Index (SLERPI): A simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus 108
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 107
null 104
Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts 103
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 103
Providing updated guidelines for the management of rheumatic diseases in Italy with the ADAPTE methodology: A project by the Italian Society for Rheumatology 103
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 103
Totale 17.321
Categoria #
all - tutte 102.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 253
Totale 102.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021437 0 0 0 0 0 0 0 0 0 197 150 90
2021/20221.183 101 99 61 50 43 49 86 97 50 68 83 396
2022/2023786 118 95 34 89 97 72 37 54 78 18 53 41
2023/20241.120 49 56 22 11 81 39 24 107 40 183 167 341
2024/20254.591 172 227 454 258 490 457 160 214 756 541 490 372
2025/20269.896 887 431 1.066 1.176 1.537 688 1.117 666 1.107 1.221 0 0
Totale 21.844